Michael Rakotz to Cost-Benefit Analysis
This is a "connection" page, showing publications Michael Rakotz has written about Cost-Benefit Analysis.
Connection Strength
0.106
-
Cost-Effectiveness of Recommendations From the Surgeon General's Call-to-Action to Control Hypertension. Am J Hypertens. 2022 03 08; 35(3):225-231.
Score: 0.037
-
Return on investment of self-measured blood pressure is associated with its use in preventing false diagnoses, not monitoring hypertension. PLoS One. 2021; 16(6):e0252701.
Score: 0.035
-
Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association. Circulation. 2020 07 28; 142(4):e42-e63.
Score: 0.033